Claritev (NYSE:CTEV) SVP Tara O’neil Acquires 625 Shares of Stock

Claritev (NYSE:CTEV) SVP Tara O’neil acquired 625 shares of the business’s stock in a transaction that occurred on Monday, November 17th. The shares were purchased at an average price of $38.84 per share, with a total value of $24,275.00. Following the completion of the acquisition, the senior vice president owned 25,028 shares of the company’s stock, valued at $972,087.52. This represents a 2.56% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Claritev Stock Performance

Shares of NYSE CTEV opened at $42.05 on Wednesday. The company has a debt-to-equity ratio of 310.26, a current ratio of 1.21 and a quick ratio of 1.21. Claritev has a one year low of $4.80 and a one year high of $74.07. The business’s 50-day moving average price is $57.41 and its two-hundred day moving average price is $49.25. The company has a market capitalization of $695.09 million, a P/E ratio of -2.01 and a beta of 0.42.

Analyst Ratings Changes

A number of research firms recently commented on CTEV. Citigroup increased their price objective on Claritev from $74.00 to $80.00 and gave the stock a “buy” rating in a report on Monday, November 10th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Claritev in a report on Wednesday, November 12th. One analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Claritev presently has a consensus rating of “Hold” and an average price target of $80.00.

Hedge Funds Weigh In On Claritev

A number of institutional investors have recently made changes to their positions in the business. H&F Corporate Investors VIII Ltd. bought a new position in shares of Claritev during the 3rd quarter worth about $285,988,000. AustralianSuper Pty Ltd bought a new stake in shares of Claritev in the third quarter valued at about $169,605,000. Public Investment Fund acquired a new stake in Claritev during the third quarter worth about $68,009,000. Ares Management LLC increased its stake in Claritev by 108.5% during the first quarter. Ares Management LLC now owns 1,863,105 shares of the company’s stock valued at $43,131,000 after acquiring an additional 969,367 shares during the period. Finally, Vanguard Group Inc. acquired a new position in Claritev in the 3rd quarter valued at approximately $27,483,000. 87.15% of the stock is currently owned by institutional investors.

Claritev Company Profile

MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services.